1 Department of Neurology, Baylor College of Medicine, and the Baylor-Methodist Center for Cerebrovascular Research, Houston, Texas
The effects of intravenous infusion of 10% glycerol on regional blood flow and metabolism in infarcted hemispheres was investigated in 17 patients during the acute stage of stroke. Hemispheric blood flow (HBF) increased and cerebral oxygen consumption (CMRO2) and carbon dioxide production decreased. Glucose consumption remained constant and hemispheric respiratory quotient (HRQ) decreased. The electroencephalogram improved, and in the majority of patients neurological function also improved. Cerebrospinal fluid pressure (CSFP) did not change during infusion but decreased afterward, and no rebound occurred. Central venous pressure (CVP) and mean arterial blood pressure (MABP) increased both during and after infusion. Intracerebral venous pressure (ICVP) increased during infusion. Mechanisms which may increase HBF following infusion of 10% glycerol are discussed. Expansion of the perivascular space by removal of edema fluid within the glia seems to be a primary factor causing increased HBF. Possible explanations for the measured effects of 10% glycerol on cerebral metabolism and brain function were considered. Inhibition of uncoupling of oxidative phosphorylation (recoupling) appeared to be the most likely explanation for the improvement in brain function and metabolic changes induced with this hyperosmolar solution. The decrease in HRQ is best explained by oxidation of glycerol in the infarcted hemisphere. Intravenous infusion of glycerol appears to be a useful form of therapy in patients with acute cerebral infarction.
© 1972 American Heart Association, Inc.
Effect of Intravenous Infusion of Glycerol on Hemispheric Blood Flow and Metabolism in Patients With Acute Cerebral Infarction
Key Words: hyperosmolar agents cerebral edema recoupling intracranial pressure
This article has been cited by other articles:
![]() |
A. Shuaib, C. Xu Wang, T. Yang, and R. Noor Effects of Nonpeptide V1 Vasopressin Receptor Antagonist SR-49059 on Infarction Volume and Recovery of Function in a Focal Embolic Stroke Model Stroke, December 1, 2002; 33(12): 3033 - 3037. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Aoki, M. Tamura, Y. Itoh, T. Seto, K. Nonaka, H. Mukai, and Y. Ukai Effective Plasma Concentration of a Novel Na+/Ca2+ Channel Blocker NS-7 for Its Cerebroprotective Actions in Rats with a Transient Middle Cerebral Artery Occlusion J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 306 - 311. [Abstract] [Full Text] |
||||
![]() |
M. Davis and D. Barer Neuroprotection in acute ischaemic stroke. II: Clinical potential Vascular Medicine, August 1, 1999; 4(3): 149 - 163. [Abstract] [PDF] |
||||
![]() |
K. Mori, H. Arai, K. Nakajima, A. Tajima, and M. Maeda Hemorheological and Hemodynamic Analysis of Hypervolemic Hemodilution Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage Stroke, September 1, 1995; 26(9): 1620 - 1626. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1972 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |